Xeljanz 10 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FXTY7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,747
Award facts
- Contract value 100% obligated
- $13,746.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13.7K delivery order to AmerSourceBergen Drug Corp on January 14, 2026, for 60-count bottles of Xeljanz 10 mg tablets, with completion scheduled for January 15, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. That parent IDC, valued at $999.9 million through December 2031, serves as a comprehensive global pharmaceutical support vehicle enabling AmerSourceBergen to supply a broad range of medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare programs worldwide across multiple therapeutic domains.
As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerSourceBergen Drug Corp is a critical federal vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio with DLA demonstrates its capability to meet federal procurement requirements through open competition, with previous deliveries spanning diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This delivery order for Xeljanz, a prescription medication used in treating rheumatoid arthritis and other inflammatory conditions, exemplifies the routine pharmaceutical procurement that supports military medical readiness and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FXTY7?
SPE2DR26FXTY7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FXTY7 worth?
The government has obligated $13,747 on SPE2DR26FXTY7.
Is contract SPE2DR26FXTY7 an order under another contract?
Yes. SPE2DR26FXTY7 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTY7 competed?
The extent of competition for SPE2DR26FXTY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award